What is the Org number of Axel Ståhlbom Biologics Regulatory Advice AB?

Axel Ståhlbom Biologics Regulatory Advice AB is registered with Bolagsverket / SCB under Org 5593113276.

What is the revenue of Axel Ståhlbom Biologics Regulatory Advice AB?

Axel Ståhlbom Biologics Regulatory Advice AB reported revenue of SEK 1,2M in 2024.

How many employees does Axel Ståhlbom Biologics Regulatory Advice AB have?

Axel Ståhlbom Biologics Regulatory Advice AB employs 1 people as of the latest annual report.

Who is the chairman of Axel Ståhlbom Biologics Regulatory Advice AB?

Anne Kajsa K Kinhult Ståhlbom chairs the board of Axel Ståhlbom Biologics Regulatory Advice AB, in role since 2022.

Where is Axel Ståhlbom Biologics Regulatory Advice AB headquartered?

Axel Ståhlbom Biologics Regulatory Advice AB's registered address is Rosenstigen 4.

Riskpilot← Back to search

Sign inGet full access

Axel Ståhlbom Biologics Regulatory Advice AB

ABActive

Org 5593113276Rosenstigen 4, 141 32 HuddingeResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20211 employees

Overview Financials People & ownership Related companies

Financials

Revenue

SEK millions

EBITDA

SEK millions

Income statement

SEK thousands

Item	2021	2022	2023	2024
Revenue	1 116	989	750	1 203
Staff expenses	—	−760	−811	−824
EBITDA	549	133	−98	296
Depreciation & amort.	−0	—	—	—
EBIT	549	133	−98	296
Net financials	—	0	2	1
Profit before tax	412	270	−96	297
Tax	−85	−56	—	−42
Net profit	327	214	−96	255

Balance sheet

SEK thousands

Item	2021	2022	2023	2024
Total assets	783	889	549	817
Equity	352	466	271	525
Long-term debt	0	—	—	—
Short-term debt	294	423	278	291
Total debt	294	423	278	291

Financial ratios

5-year trend

EBITDA margin

24.6%

This company

15.8%

Market median

+56% vs market

20212024

Equity ratio

64.3%

This company

38.2%

Market median

+68% vs market

20212024

Return on equity

48.5%

This company

18.4%

Market median

+164% vs market

20212024

Net profit margin

21.2%

This company

8.1%

Market median

+162% vs market

20212024

Asset turnover

1.47×

This company

1.12×

Market median

+31% vs market

20212024

Debt / equity

0.55×

This company

0.62×

Market median

+11% vs market

20212024

Annual reports & filings

Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31

Axel Ståhlbom Biologics Regulatory Advice AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Axel Ståhlbom Biologics Regulatory Advice AB

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Axel Ståhlbom Biologics Regulatory Advice AB